Anagrelide(Xagrid)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Shire
Formulation:
CAPSULE
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Xagrid(Anagrelide) Instructions:Uses,Dosage, Side Effects

AGRYLIN is indicated specifically for managing thrombocythemia (elevated platelet count) that is secondary to underlying myeloproliferative neoplasms. These conditions include Essential Thrombocythemia (ET), Polycythemia Vera (PV), and Chronic Myelogenous Leukemia (CML). 

The treatment aims to reduce the high platelet count, thereby lowering the associated risk of thrombotic events and ameliorating related thrombo-hemorrhagic symptoms.

Generic name

Anagrelide(Xagrid)
English name
Anagrelide
Alternative Names
Xagrid
Drug prices
Indications

Treatment of thrombocythemia, secondary to myeloproliferative neoplasms (e.g., Essential Thrombocythemia, Polycythemia Vera), to reduce the elevated platelet count, the risk of thrombosis, and to ameliorate associated thrombo-hemorrhagic symptoms.

Therapeutic Target
The precise mechanism is not fully elucidated, but it suppresses megakaryocytopoiesis, reducing platelet production. It is also a phosphodiesterase 3 (PDE3) inhibitor.
Active Ingredients
Anagrelide
Dosage form
CAPSULE
specifications
0.5mg * 100 tablets/capsules
Description
Dosage and Administration

Recommended starting dose is 0.5 mg four times daily or 1 mg twice daily.

RECOMMENDED ARTICLES
RELATED ARTICLES
How Effective is Anagrelide (Agrylin) in Treatment?

Anagrelide (Agrylin) is a drug specifically used to treat thrombocythemia, and it is particularly suitable for...

Monday, October 20th, 2025, 11:30
What are the side effects of Anagrelide (Agrylin)?

Anagrelide (Agrylin) is a specific drug used to treat secondary thrombocythemia in myeloproliferative neoplasms. It...

Friday, October 17th, 2025, 15:49
Indications for Anagrelide (Agrylin)

Anagrelide (Agrylin) is a thrombocytopenic agent primarily used to treat thrombocythemia caused by...

Friday, October 17th, 2025, 13:46
Precautions for Anagrelide (Agrylin) Administration

Anagrelide (Agrylin) is a thrombocytopenic agent primarily used to treat thrombocythemia secondary to...

Monday, October 13th, 2025, 14:36
How to Use Anagrelide (Agrylin)

Anagrelide (Agrylin) is a selective thrombocytopenic agent primarily used to treat thrombocythemia secondary to...

Monday, October 13th, 2025, 14:33
Indications for Anagrelide (Agrylin)

Anagrelide (Agrylin) is a thrombocytopenic agent primarily indicated for the treatment of thrombocythemia caused by...

Wednesday, September 24th, 2025, 14:22
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved